FDA approves brepocitinib, the first oral, targeted therapy for adult dermatomyositis, backed by phase 3 VALOR data. For the first time, adults with dermatomyositis have an FDA-approved oral medicine ...
WASHINGTON, DC – The U.S. Food and Drug Administration (FDA) has approved the country’s first mRNA-based influenza vaccine, developed by Moderna. The vaccine is approved for adults aged 50 to 64 and ...
City leaders in Mauldin shared more details Thursday about a proposed 1% sales tax referendum that would fund road, infrastructure, and capital improvement projects. Leaders from the U.S. Department ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results